Treatment of Danish adolescent diabetic patients with CSII - a matched study to MDI.

Pediatric Diabetes
Jesper JohannesenJørn Nerup

Abstract

To compare two intensified insulin therapy regimens - continuous subcutaneous insulin infusion (CSII) against multiple daily insulin injection (MDI) - in Danish adolescents examined in a prospective, matched controlled study design. Thirty type 1 diabetic adolescents at CSII and 26 matched MDI controls were included in this open intention-to-treat study. Actrapid was used in both groups. Before study entry, all participants followed a brush-up course in order to minimize study effect. At each visit, the following parameters were recorded: hemoglobin A1c (HbA1c), insulin dose, weight, number of hypoglycemic and diabetic ketoacidosis (DKA) events, and the time resources used. At entry and exit of the study, diet registration and validated quality-of-life (QoL) questionnaires were filled by the participants. A non-significant decline in HbA1c was seen in both groups (p = 0.468); HbA1c decreased from 9.5 to 8.9% and from 9.7 to 9.5% in the CSII and MDI group, respectively. The insulin dose and the number of severe hypoglycemic events per patient were lower (non-significant) in the CSII group. Both groups showed increased body mass index - highest in the CSII group - and mild to moderate DKA episodes were only seen among CSII users....Continue Reading

References

Feb 1, 1997·Patient Education and Counseling·E ChantelauB Hansen
Mar 29, 2002·Diabetes/metabolism Research and Reviews·Bruce W BodePaul C Davidson
May 17, 2002·Journal of Pediatric Endocrinology & Metabolism : JPEM·K RaileH P Schwarz
Jul 31, 2002·Diabetic Medicine : a Journal of the British Diabetic Association·D BruttomessoA Tiengo
Mar 29, 2003·Diabetes Care·Jill Weissberg-BenchellRoopa Seshadri
Oct 23, 2003·JAMA : the Journal of the American Medical Association·UNKNOWN Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Resea
Dec 6, 2003·The Journal of Pediatrics·Steven M WilliSharon Schwarz
Jan 14, 2005·Journal of Pediatric Endocrinology & Metabolism : JPEM·Nicole S GlaserBeth Goodlin-Jones

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.